BIOMARKER PANEL FOR IN VITRO TESTING IN THE DIAGNOSIS OF LIVER DISEASE

Abstract

In recent years, in an attempt to identify new therapies and more accurate biomarkers for the early diagnosis and treatment of liver diseases, to date, no biomarkers exist that allow for a definitive determination of the prognosis of patients with hepatic fibrosis. The present invention relates to a panel of biomarkers for in vitro testing in the diagnosis of liver disease, particularly for clinical diagnosis, with an emphasis on in vitro tests for diagnosing diseases associated with fibrosis, such as the detection of hepatic fibrosis processes using non-invasive methods in patients, as well as in individuals without known liver disease.